Reports
Sale
Global Paracetamol Market Size, Trends, Analysis, Report: By Dosage Type: Tablet, Capsules, Others; By Applications: Headache and Fever, Cold and Cough, Muscle Cramps, Others; Regional Analysis; Market Dynamics; Patent Analysis; Grants Analysis; Clinical Trials Analysis; Funding and Investment Analysis; Competitive Landscape; 2024-2032
Global Paracetamol Market Outlook
The global paracetamol market size was valued at USD 1.7 billion in 2023, driven by increasing innovation across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 to achieve a value of USD 2.5 billion by 2032.
Paracetamol: Introduction
Paracetamol, also known as Panadol, Calpol, or Alvedon, is an analgesic and antipyretic medication that is used to temporarily alleviate mild-to-moderate pain and fever. It is commonly included as an ingredient in cold and flu medications and can also be used individually. Paracetamol and acetaminophen (Tylenol) are the same drugs but they are named differently in different countries. Paracetamol is the name assigned using the International Nonproprietary Name (INN) system, while acetaminophen is the name assigned using the United States Adopted Names (USAN) system. Paracetamol is used in Europe, Australia, New Zealand, and India, while acetaminophen is used in countries such as the United States, Canada, and Japan. Generally, the INN and USAN names for a drug are the same and do not differ between countries.
Global Paracetamol Market Analysis
The global market for paracetamol has experienced significant growth and is poised for steady growth in the coming years as well. The market is poised to grow due to recent developments for example, Dr. Bhaumik Pandya's innovative formulation, aimed at combating liver toxicity associated with paracetamol (PCM), is a significant innovation. By increasing PCM's water solubility, this patented innovation not only enhances safety by preventing liver damage but also enables precise dosing. This will enable patients to take the exact required dosage, such as 250mg, instead of opting for higher doses like 500mg or 650mg, potentially revolutionizing the consumption pattern of paracetamol. This advancement could lead to increased demand for this novel formulation, influencing the global paracetamol market growth.
In August 2023, the market for paracetamol faced a challenge when the prices of its key ingredients suddenly surged. This caught both pharmaceutical companies and healthcare professionals off guard. The unexpected cost escalation could hinder the market growth, leading to either higher retail prices or supply chain disruptions. To mitigate these effects, pharmaceutical companies may need to increase their research and development efforts to create more cost-effective versions of paracetamol. This could stimulate innovation but might also introduce market volatility. Overall, while Dr. Pandya's invention offers a promising way to expand the market and improve patient safety, the increase in ingredient prices presents a hurdle that the industry must overcome to sustain and promise market growth.
Global Paracetamol Market Segmentations
Market Breakup by Dosage Type
- Tablet
- Capsules
- Others
Market Breakup by Applications
- Headache and Fever
- Cold and Cough
- Muscle Cramps
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Paracetamol Market Overview
The market has been witnessing significant market growth due to the rising frequency of seasonal flu causing cold and fever coupled with body pain. Paracetamol is used as a primary treatment for mild to moderate cases of fever, headaches, and body pain among others. The rise in frequent cases of fever and cold among the geriatric population, adults, and pediatrics is leading to increased paracetamol market demand.
The convenience of over the counter (OTC) availability of the medication contributes to the increased demand, particularly for common pain and fever relief, adding further value to the paracetamol market share. Paracetamol is often combined with other active ingredients to address multiple symptoms in a single medication (e.g., paracetamol with decongestants for cold relief). Due to the requirement of paracetamol in such combinational dosages, the market is expected to keep expanding for the forecast period.
Global Paracetamol Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- GlaxoSmithKline plc
- Teva Pharmaceuticals USA, Inc.
- Sanofi
- Mallinckrodt Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- Geno Pharma
- Biological E
- CFL Pharma
- Cipla
- Dr. Reddy’s Lab
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Dosage Type |
|
| Breakup by Applications |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Paracetamol Market Overview
3.1 Global Paracetamol Market Historical Value (2017-2023)
3.2 Global Paracetamol Market Forecast Value (2024-2032)
4 Global Paracetamol Market Landscape
4.1 Global Paracetamol: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Paracetamol: Product Landscape
4.2.1 Analysis by Dosage Type
4.2.2 Analysis by Applications
5 Global Paracetamol Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Paracetamol Market Segmentation
6.1 Global Paracetamol Market by Dosage Type
6.1.1 Market Overview
6.1.2 Tablet
6.1.3 Capsules
6.1.4 Others
6.2 Global Paracetamol Market by Applications
6.2.1 Market Overview
6.2.2 Headache and Fever
6.2.3 Cold and Cough
6.2.4 Muscle Cramps
6.2.5 Others
6.3 Global Paracetamol Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Paracetamol Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Paracetamol Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Paracetamol Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Paracetamol Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Paracetamol Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Clinical Trials Analysis
15.1 Analysis by Trial Registration Year
15.2 Analysis by Trial Status
15.3 Analysis by Trial Phase
15.4 Analysis by Therapeutic Area
15.5 Analysis by Geography
16 Funding and Investment Analysis
16.1 Analysis by Funding Instances
16.2 Analysis by Type of Funding
16.3 Analysis by Funding Amount
16.4 Analysis by Leading Players
16.5 Analysis by Leading Investors
16.6 Analysis by Geography
17 Partnership and Collaborations Analysis
17.1 Analysis by Partnership Instances
17.2 Analysis by Type of Partnership
17.3 Analysis by Leading Players
17.4 Analysis by Geography
18 Supplier Landscape
18.1 GlaxoSmithKline plc
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Teva Pharmaceuticals USA, Inc.
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 Sanofi
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 Mallinckrodt Pharmaceuticals
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 Sun Pharmaceutical Industries Ltd.
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Geno Pharma
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 Biological E
18.7.1 Product Portfolio
18.7.2 Demographic Reach and Achievements
18.7.3 Mergers and Acquisitions
18.7.4 Certifications
18.8 CFL Pharma
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Cipla
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Dr. Reddy’s Lab
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1.7 billion in 2023, driven by increased incidence of seasonal symptoms.
The market is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032, likely to reach a market value of USD 2.5 billion by 2032.
The rising geriatric population and rising cases of common flu and fever among geriatric and paediatric populations are the major factors driving market growth.
The increasing research and development on finding the potential of paracetamol in treating more medical conditions is a major trend influencing the market growth.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different dosages in the market can be categorised into tablet and capsules, among others.
The medicine finds wide applications in headaches, fever, cold and cough, and muscle cramps, among others.
Key players involved in the market are GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc.
Sanofi, Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Geno Pharma, Biological E, CFL Pharma, Cipla, and Dr. Reddy’s Lab.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER